nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetohydroxamic Acid—Reticulocytosis—Gemcitabine—urinary bladder cancer	0.098	0.141	CcSEcCtD
Acetohydroxamic Acid—Hydroxyurea—RRM2—urinary bladder cancer	0.0693	1	CrCbGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—LOXL4—urinary bladder cancer	0.0204	0.0862	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—urinary bladder cancer	0.0166	0.0702	CbGpPWpGaD
Acetohydroxamic Acid—Thrombophlebitis—Mitomycin—urinary bladder cancer	0.0162	0.0233	CcSEcCtD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—LOXL1—urinary bladder cancer	0.0154	0.0654	CbGpPWpGaD
Acetohydroxamic Acid—Renal impairment—Mitomycin—urinary bladder cancer	0.0147	0.0212	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal symptom NOS—Fluorouracil—urinary bladder cancer	0.0137	0.0197	CcSEcCtD
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—MMP9—urinary bladder cancer	0.0129	0.0545	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—RBX1—urinary bladder cancer	0.0122	0.0517	CbGpPWpGaD
Acetohydroxamic Acid—Ill-defined disorder—Valrubicin—urinary bladder cancer	0.0114	0.0164	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Valrubicin—urinary bladder cancer	0.0113	0.0163	CcSEcCtD
Acetohydroxamic Acid—Malaise—Valrubicin—urinary bladder cancer	0.011	0.0159	CcSEcCtD
Acetohydroxamic Acid—MMP12—Collagen degradation—MMP9—urinary bladder cancer	0.0107	0.0451	CbGpPWpGaD
Acetohydroxamic Acid—Renal failure—Mitomycin—urinary bladder cancer	0.0106	0.0153	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Valrubicin—urinary bladder cancer	0.0103	0.0148	CcSEcCtD
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—TNF—urinary bladder cancer	0.00991	0.0419	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—urinary bladder cancer	0.00984	0.0416	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SRC—urinary bladder cancer	0.00907	0.0384	CbGpPWpGaD
Acetohydroxamic Acid—Alopecia—Mitomycin—urinary bladder cancer	0.00857	0.0123	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00824	0.0119	CcSEcCtD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—urinary bladder cancer	0.00795	0.0336	CbGpPWpGaD
Acetohydroxamic Acid—Ill-defined disorder—Mitomycin—urinary bladder cancer	0.00783	0.0113	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Mitomycin—urinary bladder cancer	0.0078	0.0112	CcSEcCtD
Acetohydroxamic Acid—Malaise—Mitomycin—urinary bladder cancer	0.00761	0.011	CcSEcCtD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—CDH1—urinary bladder cancer	0.00745	0.0315	CbGpPWpGaD
Acetohydroxamic Acid—Asthenia—Valrubicin—urinary bladder cancer	0.00717	0.0103	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Mitomycin—urinary bladder cancer	0.0071	0.0102	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TERT—urinary bladder cancer	0.00701	0.0297	CbGpPWpGaD
Acetohydroxamic Acid—Deep vein thrombosis—Methotrexate—urinary bladder cancer	0.00687	0.00989	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CDK4—urinary bladder cancer	0.00687	0.0291	CbGpPWpGaD
Acetohydroxamic Acid—Thrombophlebitis—Fluorouracil—urinary bladder cancer	0.00673	0.0097	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Mitomycin—urinary bladder cancer	0.00657	0.00946	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Valrubicin—urinary bladder cancer	0.00636	0.00915	CcSEcCtD
Acetohydroxamic Acid—Rash—Valrubicin—urinary bladder cancer	0.0063	0.00908	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Valrubicin—urinary bladder cancer	0.0063	0.00907	CcSEcCtD
Acetohydroxamic Acid—Headache—Valrubicin—urinary bladder cancer	0.00626	0.00902	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Gemcitabine—urinary bladder cancer	0.00623	0.00897	CcSEcCtD
Acetohydroxamic Acid—Haemolytic anaemia—Cisplatin—urinary bladder cancer	0.00612	0.00882	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Mitomycin—urinary bladder cancer	0.00599	0.00862	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—RB1—urinary bladder cancer	0.00597	0.0253	CbGpPWpGaD
Acetohydroxamic Acid—Lethargy—Fluorouracil—urinary bladder cancer	0.00595	0.00857	CcSEcCtD
Acetohydroxamic Acid—Nausea—Valrubicin—urinary bladder cancer	0.00594	0.00855	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Mitomycin—urinary bladder cancer	0.00594	0.00855	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00568	0.00817	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CREBBP—urinary bladder cancer	0.00548	0.0232	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—RHOA—urinary bladder cancer	0.00542	0.0229	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—MMP9—urinary bladder cancer	0.00539	0.0228	CbGpPWpGaD
Acetohydroxamic Acid—Renal failure—Thiotepa—urinary bladder cancer	0.00534	0.00769	CcSEcCtD
Acetohydroxamic Acid—Feeling hot—Epirubicin—urinary bladder cancer	0.00498	0.00717	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—RHOA—urinary bladder cancer	0.00496	0.021	CbGpPWpGaD
Acetohydroxamic Acid—Asthenia—Mitomycin—urinary bladder cancer	0.00494	0.00712	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—PTGS2—urinary bladder cancer	0.00491	0.0208	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CXCL8—urinary bladder cancer	0.00476	0.0201	CbGpPWpGaD
Acetohydroxamic Acid—Feeling hot—Doxorubicin—urinary bladder cancer	0.00461	0.00664	CcSEcCtD
Acetohydroxamic Acid—Abdominal discomfort—Cisplatin—urinary bladder cancer	0.00458	0.00659	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—IL2—urinary bladder cancer	0.00455	0.0192	CbGpPWpGaD
Acetohydroxamic Acid—Renal failure—Gemcitabine—urinary bladder cancer	0.00449	0.00647	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CCND1—urinary bladder cancer	0.00443	0.0188	CbGpPWpGaD
Acetohydroxamic Acid—Vomiting—Mitomycin—urinary bladder cancer	0.00438	0.00631	CcSEcCtD
Acetohydroxamic Acid—Rash—Mitomycin—urinary bladder cancer	0.00434	0.00625	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Mitomycin—urinary bladder cancer	0.00434	0.00625	CcSEcCtD
Acetohydroxamic Acid—Headache—Mitomycin—urinary bladder cancer	0.00431	0.00621	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Thiotepa—urinary bladder cancer	0.00431	0.0062	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—MMP9—urinary bladder cancer	0.0043	0.0182	CbGpPWpGaD
Acetohydroxamic Acid—Renal failure—Cisplatin—urinary bladder cancer	0.00419	0.00603	CcSEcCtD
Acetohydroxamic Acid—Tension—Thiotepa—urinary bladder cancer	0.00416	0.006	CcSEcCtD
Acetohydroxamic Acid—Nervousness—Thiotepa—urinary bladder cancer	0.00412	0.00594	CcSEcCtD
Acetohydroxamic Acid—Nausea—Mitomycin—urinary bladder cancer	0.00409	0.00589	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CCND1—urinary bladder cancer	0.00405	0.0172	CbGpPWpGaD
Acetohydroxamic Acid—Anaemia—Thiotepa—urinary bladder cancer	0.00392	0.00565	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CDKN1A—urinary bladder cancer	0.00392	0.0166	CbGpPWpGaD
Acetohydroxamic Acid—Renal failure—Etoposide—urinary bladder cancer	0.00383	0.00552	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—EP300—urinary bladder cancer	0.00373	0.0158	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—SRC—urinary bladder cancer	0.00363	0.0154	CbGpPWpGaD
Acetohydroxamic Acid—Alopecia—Gemcitabine—urinary bladder cancer	0.00362	0.00522	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Thiotepa—urinary bladder cancer	0.0036	0.00519	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Fluorouracil—urinary bladder cancer	0.00356	0.00513	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—MYC—urinary bladder cancer	0.00356	0.015	CbGpPWpGaD
Acetohydroxamic Acid—Thrombophlebitis—Methotrexate—urinary bladder cancer	0.0035	0.00504	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—EGFR—urinary bladder cancer	0.00348	0.0147	CbGpPWpGaD
Acetohydroxamic Acid—Alopecia—Cisplatin—urinary bladder cancer	0.00338	0.00486	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—TNF—urinary bladder cancer	0.00331	0.014	CbGpPWpGaD
Acetohydroxamic Acid—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.00331	0.00477	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Thiotepa—urinary bladder cancer	0.0033	0.00476	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Gemcitabine—urinary bladder cancer	0.0033	0.00475	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.00328	0.00472	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MYC—urinary bladder cancer	0.00325	0.0138	CbGpPWpGaD
Acetohydroxamic Acid—Anaemia—Fluorouracil—urinary bladder cancer	0.00324	0.00467	CcSEcCtD
Acetohydroxamic Acid—Malaise—Gemcitabine—urinary bladder cancer	0.00322	0.00464	CcSEcCtD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—CDH1—urinary bladder cancer	0.00312	0.0132	CbGpPWpGaD
Acetohydroxamic Acid—Tremor—Cisplatin—urinary bladder cancer	0.00312	0.00449	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Etoposide—urinary bladder cancer	0.00309	0.00446	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Methotrexate—urinary bladder cancer	0.00309	0.00446	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.00309	0.00445	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Cisplatin—urinary bladder cancer	0.00308	0.00443	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.00303	0.00437	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Thiotepa—urinary bladder cancer	0.00301	0.00434	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Gemcitabine—urinary bladder cancer	0.003	0.00433	CcSEcCtD
Acetohydroxamic Acid—Malaise—Cisplatin—urinary bladder cancer	0.003	0.00432	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00299	0.00431	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Thiotepa—urinary bladder cancer	0.00299	0.0043	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Epirubicin—urinary bladder cancer	0.00298	0.00429	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Fluorouracil—urinary bladder cancer	0.00295	0.00425	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—TP53—urinary bladder cancer	0.00292	0.0124	CbGpPWpGaD
Acetohydroxamic Acid—Lethargy—Epirubicin—urinary bladder cancer	0.0029	0.00417	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00285	0.00411	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Etoposide—urinary bladder cancer	0.00283	0.00407	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Cisplatin—urinary bladder cancer	0.00282	0.00407	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Etoposide—urinary bladder cancer	0.00282	0.00406	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Cisplatin—urinary bladder cancer	0.0028	0.00403	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Gemcitabine—urinary bladder cancer	0.00278	0.004	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Doxorubicin—urinary bladder cancer	0.00276	0.00397	CcSEcCtD
Acetohydroxamic Acid—Malaise—Etoposide—urinary bladder cancer	0.00275	0.00396	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Fluorouracil—urinary bladder cancer	0.00273	0.00393	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Doxorubicin—urinary bladder cancer	0.00268	0.00386	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TP53—urinary bladder cancer	0.00267	0.0113	CbGpPWpGaD
Acetohydroxamic Acid—Anorexia—Cisplatin—urinary bladder cancer	0.00259	0.00373	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Etoposide—urinary bladder cancer	0.00256	0.00369	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00253	0.00365	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00252	0.00362	CcSEcCtD
Acetohydroxamic Acid—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00251	0.00362	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Gemcitabine—urinary bladder cancer	0.00251	0.00362	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00249	0.00359	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Thiotepa—urinary bladder cancer	0.00249	0.00358	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00247	0.00356	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.0024	0.00346	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Etoposide—urinary bladder cancer	0.00237	0.00342	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Cisplatin—urinary bladder cancer	0.00236	0.0034	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00236	0.0034	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00234	0.00338	CcSEcCtD
Acetohydroxamic Acid—Depression—Methotrexate—urinary bladder cancer	0.00233	0.00336	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Methotrexate—urinary bladder cancer	0.0023	0.00331	CcSEcCtD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—MMP9—urinary bladder cancer	0.00226	0.00956	CbGpPWpGaD
Acetohydroxamic Acid—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00224	0.00322	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Thiotepa—urinary bladder cancer	0.0022	0.00317	CcSEcCtD
Acetohydroxamic Acid—Rash—Thiotepa—urinary bladder cancer	0.00218	0.00315	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Thiotepa—urinary bladder cancer	0.00218	0.00314	CcSEcCtD
Acetohydroxamic Acid—Headache—Thiotepa—urinary bladder cancer	0.00217	0.00313	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Etoposide—urinary bladder cancer	0.00216	0.00311	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Epirubicin—urinary bladder cancer	0.00215	0.0031	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00215	0.00309	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Etoposide—urinary bladder cancer	0.00215	0.00309	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Gemcitabine—urinary bladder cancer	0.00209	0.00301	CcSEcCtD
Acetohydroxamic Acid—Nausea—Thiotepa—urinary bladder cancer	0.00206	0.00296	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Etoposide—urinary bladder cancer	0.00205	0.00295	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Doxorubicin—urinary bladder cancer	0.00199	0.00286	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Cisplatin—urinary bladder cancer	0.00195	0.00281	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Methotrexate—urinary bladder cancer	0.00185	0.00267	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Gemcitabine—urinary bladder cancer	0.00185	0.00267	CcSEcCtD
Acetohydroxamic Acid—Rash—Gemcitabine—urinary bladder cancer	0.00184	0.00265	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Gemcitabine—urinary bladder cancer	0.00184	0.00264	CcSEcCtD
Acetohydroxamic Acid—Headache—Gemcitabine—urinary bladder cancer	0.00183	0.00263	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Fluorouracil—urinary bladder cancer	0.00182	0.00262	CcSEcCtD
Acetohydroxamic Acid—Rash—Fluorouracil—urinary bladder cancer	0.00181	0.0026	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Fluorouracil—urinary bladder cancer	0.0018	0.0026	CcSEcCtD
Acetohydroxamic Acid—Headache—Fluorouracil—urinary bladder cancer	0.00179	0.00258	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Etoposide—urinary bladder cancer	0.00179	0.00257	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Epirubicin—urinary bladder cancer	0.00173	0.0025	CcSEcCtD
Acetohydroxamic Acid—Nausea—Gemcitabine—urinary bladder cancer	0.00173	0.00249	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Cisplatin—urinary bladder cancer	0.00173	0.00249	CcSEcCtD
Acetohydroxamic Acid—Rash—Cisplatin—urinary bladder cancer	0.00171	0.00247	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Cisplatin—urinary bladder cancer	0.00171	0.00246	CcSEcCtD
Acetohydroxamic Acid—Nausea—Fluorouracil—urinary bladder cancer	0.0017	0.00245	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00169	0.00244	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Methotrexate—urinary bladder cancer	0.00169	0.00243	CcSEcCtD
Acetohydroxamic Acid—Tension—Epirubicin—urinary bladder cancer	0.00168	0.00242	CcSEcCtD
Acetohydroxamic Acid—Nervousness—Epirubicin—urinary bladder cancer	0.00166	0.00239	CcSEcCtD
Acetohydroxamic Acid—Malaise—Methotrexate—urinary bladder cancer	0.00165	0.00237	CcSEcCtD
Acetohydroxamic Acid—Nausea—Cisplatin—urinary bladder cancer	0.00161	0.00232	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Doxorubicin—urinary bladder cancer	0.00161	0.00231	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00159	0.00228	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Etoposide—urinary bladder cancer	0.00158	0.00228	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Epirubicin—urinary bladder cancer	0.00158	0.00227	CcSEcCtD
Acetohydroxamic Acid—Rash—Etoposide—urinary bladder cancer	0.00157	0.00226	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Etoposide—urinary bladder cancer	0.00157	0.00226	CcSEcCtD
Acetohydroxamic Acid—Headache—Etoposide—urinary bladder cancer	0.00156	0.00224	CcSEcCtD
Acetohydroxamic Acid—Tension—Doxorubicin—urinary bladder cancer	0.00155	0.00223	CcSEcCtD
Acetohydroxamic Acid—Malaise—Epirubicin—urinary bladder cancer	0.00154	0.00222	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Methotrexate—urinary bladder cancer	0.00154	0.00221	CcSEcCtD
Acetohydroxamic Acid—Nervousness—Doxorubicin—urinary bladder cancer	0.00154	0.00221	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Epirubicin—urinary bladder cancer	0.00151	0.00217	CcSEcCtD
Acetohydroxamic Acid—Nausea—Etoposide—urinary bladder cancer	0.00148	0.00213	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00147	0.00211	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Doxorubicin—urinary bladder cancer	0.00146	0.0021	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Epirubicin—urinary bladder cancer	0.00145	0.00209	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Epirubicin—urinary bladder cancer	0.00144	0.00207	CcSEcCtD
Acetohydroxamic Acid—Malaise—Doxorubicin—urinary bladder cancer	0.00143	0.00205	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Methotrexate—urinary bladder cancer	0.00142	0.00205	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Doxorubicin—urinary bladder cancer	0.0014	0.00201	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Doxorubicin—urinary bladder cancer	0.00134	0.00193	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Doxorubicin—urinary bladder cancer	0.00133	0.00192	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Epirubicin—urinary bladder cancer	0.00133	0.00191	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Methotrexate—urinary bladder cancer	0.0013	0.00187	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00129	0.00185	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Methotrexate—urinary bladder cancer	0.00128	0.00185	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Doxorubicin—urinary bladder cancer	0.00123	0.00177	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00123	0.00177	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Epirubicin—urinary bladder cancer	0.00121	0.00175	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.0012	0.00173	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Epirubicin—urinary bladder cancer	0.0012	0.00173	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00115	0.00166	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00112	0.00162	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00111	0.0016	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Doxorubicin—urinary bladder cancer	0.00111	0.0016	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Methotrexate—urinary bladder cancer	0.00107	0.00154	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00106	0.00153	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Epirubicin—urinary bladder cancer	0.001	0.00144	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Methotrexate—urinary bladder cancer	0.000948	0.00136	CcSEcCtD
Acetohydroxamic Acid—Rash—Methotrexate—urinary bladder cancer	0.00094	0.00135	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Methotrexate—urinary bladder cancer	0.000939	0.00135	CcSEcCtD
Acetohydroxamic Acid—Headache—Methotrexate—urinary bladder cancer	0.000934	0.00134	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Doxorubicin—urinary bladder cancer	0.000926	0.00133	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Epirubicin—urinary bladder cancer	0.000887	0.00128	CcSEcCtD
Acetohydroxamic Acid—Nausea—Methotrexate—urinary bladder cancer	0.000885	0.00127	CcSEcCtD
Acetohydroxamic Acid—Rash—Epirubicin—urinary bladder cancer	0.000879	0.00127	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Epirubicin—urinary bladder cancer	0.000879	0.00127	CcSEcCtD
Acetohydroxamic Acid—Headache—Epirubicin—urinary bladder cancer	0.000874	0.00126	CcSEcCtD
Acetohydroxamic Acid—Nausea—Epirubicin—urinary bladder cancer	0.000828	0.00119	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Doxorubicin—urinary bladder cancer	0.000821	0.00118	CcSEcCtD
Acetohydroxamic Acid—Rash—Doxorubicin—urinary bladder cancer	0.000814	0.00117	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Doxorubicin—urinary bladder cancer	0.000813	0.00117	CcSEcCtD
Acetohydroxamic Acid—Headache—Doxorubicin—urinary bladder cancer	0.000808	0.00116	CcSEcCtD
Acetohydroxamic Acid—Nausea—Doxorubicin—urinary bladder cancer	0.000767	0.0011	CcSEcCtD
